Fenfluraminum [Inn-Latin] en es it fr

Fenfluraminum [Inn-Latin] Brand names, Fenfluraminum [Inn-Latin] Analogs

Fenfluraminum [Inn-Latin] Brand Names Mixture

  • No information avaliable

Fenfluraminum [Inn-Latin] Chemical_Formula


Fenfluraminum [Inn-Latin] RX_link


Fenfluraminum [Inn-Latin] fda sheet

Fenfluraminum [Inn-Latin] msds (material safety sheet)

Fenfluraminum [Inn-Latin] Synthesis Reference

No information avaliable

Fenfluraminum [Inn-Latin] Molecular Weight

231.257 g/mol

Fenfluraminum [Inn-Latin] Melting Point

108-112 oC at 1.20E+01 mm Hg

Fenfluraminum [Inn-Latin] H2O Solubility

412 mg/L

Fenfluraminum [Inn-Latin] State


Fenfluraminum [Inn-Latin] LogP


Fenfluraminum [Inn-Latin] Dosage Forms

Capsule (sustained-release); Tablet

Fenfluraminum [Inn-Latin] Indication

For the management of exogenous obesity as a short-term (a few weeks) adjunct in a regimen of weight reduction based on caloric restriction.

Fenfluraminum [Inn-Latin] Pharmacology

Used to treat diabetes and obesity, Fenfluramine decreases caloric intake by increasing serotonin levels in the brain's synapses. Fenfluramine acts as a serotonin reuptake inhibitor. It also causes release of serotonin from the synaptosomes.

Fenfluraminum [Inn-Latin] Absorption

No information avaliable

Fenfluraminum [Inn-Latin] side effects and Toxicity

No information avaliable

Fenfluraminum [Inn-Latin] Patient Information

No information avaliable

Fenfluraminum [Inn-Latin] Organisms Affected

Humans and other mammals